PCI Pharma Services announced that it made a series of infrastructure investments to deepen its sterile fill-finish and advanced drug delivery capabilities. Philadelphia-based PCI says its latest investments come as part of a broader commitment exceeding $1 billion. Its investment spans across its U.S. and European operations. The company hopes to provide seamless support for…
BD, Suttons Creek partner to support drug delivery combination products
BD (NYSE:BDX) announced today that it entered into a strategic, non-exclusive collaboration with Suttons Creek, a BlueRidge Life Sciences company. The companies aim to help pharmaceutical and biotech companies more efficiently navigate the engineering, testing, quality and regulatory complexity associated with combination product development. Under the collaboration, ZebraSci, BD’s device-agnostic combination product testing organization, is…
AbbVie to build $1.4B plant, create 730 jobs in North Carolina
AbbVie (NYSE:ABBV) today announced a $1.4 billion investment to build a new pharmaceutical manufacturing campus in Durham, North Carolina. The 185-acre campus will integrate advanced manufacturing and laboratory technologies with AI to support the production of AbbVie’s immunology, neuroscience and oncology medicines. It marks the latest significant investment in pharmaceutical manufacturing after the company outlined…
Kincell Bio to expand North Carolina manufacturing site
Kincell Bio announced that it made a significant strategic investment in the expansion of its Research Triangle Park, North Carolina, facility. The contract development and manufacturing organization (CDMO) supports autologous and allogenic cell therapy programs. It expects the new expansion to support clients as they advance from late-stage clinical CMC development through commercialization and post-approval…
West Pharmaceutical Services opens expanded Dublin facility for injectable therapies
West Pharmaceutical Services (NYSE:WST) announced the opening of a new facility for contract services in Dublin, Ireland. IDA Ireland, the foreign direct investment arm for the Irish government, shared the announcement of the Damastown site’s opening. The 165,000-square-foot expansion enhances West’s contract services. It helps meet the growing demand for high-volume treatments, including for diabetes…
Thermo Fisher, SHL Medical collab on drug delivery device production
Thermo Fisher Scientific today announced a strategic collaboration with drug delivery system provider SHL Medical. The collaboration coincides with the expansion of sterile fill-finish and auto-injector final assembly capacity at its Ridgefield, New Jersey site. Together, Thermo Fisher says its investments establish a fully integrated U.S.-based offering across sterile manufacturing, device assembly and commercial packaging…
Wilmington PharmaTech invests $50M in API manufacturing expansion
Wilmington PharmaTech announced a $50 million investment to expand its Delaware campus for active pharmaceutical ingredient (API) manufacturing. Newark, Delaware-based Wilmington PharmaTech said the expansion more than doubles its current API reactor capacity. It adds two new 10,000-liter reactor suites to increase commercial-scale manufacturing capabilities. This supports growing demand for high-quality, U.S.-based manufacturing as the…
Cambrex expands US, European API manufacturing footprint
Cambrex announced today that it achieved multiple milestones in its effort to expand its active pharmaceutical ingredient (API) manufacturing. East Rutherford, New Jersey-based Cambrex said it completed the initial engineering studies for a new, large-scale API manufacturing plant in Charles City, Iowa. It also added further investment to support its Milan, Italy, site. The latest…
Plastic Ingenuity expands operations into Europe with Spezi-Pack acquisition
Plastic Ingenuity announced today that it’s expanding its operations into Europe with the acquisition of Spezi-Pack. Located near Dresden, Germany, Spezi-Pack is an established thermoforming company. Madison, Wisconsin-based Plastic Ingenuity said the expansion enables it to offer regional European manufacturing for medical device and pharmaceutical packaging. The acquisition helps to increase efficiencies along the value…
BioDuro, Cenra launch joint venture for API manufacturing
BioDuro announced that it established a joint venture with Cenra API Solutions, also known as Chunghwa Chemical Synthesis & Biotech Co. The joint venture aims to combine the services of the CRDMO and a pharmaceutical chemical manufacturer. They hope to add significant commercial-scale active pharmaceutical ingredient (API) manufacturing capacity at Cenra’s campus in Taipei, Taiwan, to…